Dublin, June 20, 2017 -- Research and Markets has announced the addition of the "Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)" report to their offering.
The global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016- 2021, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis.
Over the recent years, the global pain management drugs industry has been growing rapidly with the increasing demand for drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the pain management drugs market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions.
The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Market (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
- Pain Management Drugs Market
- By Type of Drugs
- Application Market
- Drug Pipeline - By Developer, Phase, Indication and Status
Regional Markets - N. America, Europe, APAC, Latin America, RoW (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
- Pain Management Drugs Market
- By Type of Drugs
Country Analysis - US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
- Pain Management Drugs Market
Other Report Highlights
- Market Dynamics - Trends, Drivers, Challenges
- Policy and Regulation
- Company Analysis - Endo Pharmaceuticals, AstraZeneca, Novartis , Purdue Pharma, GSK, Tetra Bio Pharma, Allergen, Boehringer-Ingelheim, Sanofi, Pfizer
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
4. Pain Management Drugs Market Outlook
5. Global Pain Management Drugs Market: Growth and Forecast
6. Global Pain Management Drugs Market: By Region
7. North America Pain Management Drugs Market
8. North America Pain Management Drugs Market, By Country
9. North America Pain Management Drugs Market: By Type
10. Europe Pain Management Drugs Market
11. Europe Pain Management Drugs Market, By Country
12. Europe Pain Management Drugs Market: By Type
13. Asia Pacific Pain Management Drugs Management Market
14. Asia Pacific Pain Management Drugs Market, By Country
15. Asia Pacific Drug Pain Management Market: By Type
16. Latin America Pain Management Drugs Market
17. Latin America Pain Management Drugs Market, By Country
18. Latin America Pain Management Drugs Market: By Type
19. ROW Pain Management Drugs Market
20. Market Dynamics
21. Company Profiles
22. Pipeline Analysis
Companies Mentioned
- Allergan
- Astrazeneca plc
- Boehringer Ingelheim
- Endo Pharmaceuticals
- Glaxosmithkline
- Novartis
- Pfizer
- Purdue Pharma
- Sanofi
- Tetra Bio Pharma
For more information about this report visit https://www.researchandmarkets.com/research/2zn69x/global_pain
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Analgesics


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



